tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Barinthus Biotherapeutics price target lowered to $3 from $5 at H.C. Wainwright

H.C. Wainwright analyst Yi Chen lowered the firm’s price target on Barinthus Biotherapeutics (BRNS) to $3 from $5 and keeps a Buy rating on the shares after the company announced a corporate restructuring. The firm has reduced the probability of approval for VTP-300 from 45% to 15%.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1